Healthcare Sector

GILD

Market Tracker

  • GILD (Selected)

    Gilead Sciences, Inc.

GILD Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

GILD Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

GILD Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

GILD Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/16/2026 PUT $110.00 1,640 +857 +109.45%
12/12/2025 PUT $121.00 337 +237 +237.00%
12/19/2025 CALL $122.00 230 +156 +210.81%
01/16/2026 CALL $120.00 2,758 +103 +3.88%
12/12/2025 CALL $123.00 204 +78 +61.90%
01/21/2028 PUT $95.00 73 +73
12/12/2025 CALL $116.00 81 -26 -24.30%
12/12/2025 PUT $120.00 156 -38 -19.59%
12/12/2025 CALL $122.00 259 -39 -13.09%
12/19/2025 CALL $120.00 924 -39 -4.05%
12/19/2025 CALL $125.00 1,153 -55 -4.55%
12/12/2025 PUT $119.00 297 -84 -22.05%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

GILD Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 38.12M 2.91B
Income Fund of America Inc 2.70% 33.74M 2.58B
Vanguard 500 Index Fund 2.32% 28.99M 2.21B
Dodge & Cox Stock Fund 2.02% 25.19M 1.92B
Washington Mutual Investors Fund 1.57% 19.64M 1.5B
American Balanced Fund 1.37% 17.14M 1.31B
American Mutual Fund Inc 1.33% 16.67M 1.27B
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 16.4M 1.25B
Fidelity 500 Index Fund 1.10% 13.75M 1.05B
SPDR S&P 500 ETF Trust 1.08% 13.5M 1.03B

GILD News

  • Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition

    12/06 10:30 am

    GlobeNewswire Inc.

    Read more
  • Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away

    12/03 10:34 am

    The Motley Fool

    Read more
  • Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

    12/01 08:00 am

    GlobeNewswire Inc.

    Read more
  • U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

    11/27 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

    11/27 10:00 am

    GlobeNewswire Inc.

    Read more
  • Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

    11/13 02:55 pm

    Benzinga

    Read more
  • Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend

    11/07 11:10 am

    Benzinga

    Read more
  • Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

    11/03 10:00 am

    GlobeNewswire Inc.

    Read more
  • Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026

    10/31 01:41 pm

    Benzinga

    Read more
  • Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030

    10/31 06:19 am

    Benzinga

    Read more
  • CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High

    10/29 10:20 am

    Benzinga

    Read more
  • Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia

    10/22 06:00 am

    GlobeNewswire Inc.

    Read more
  • Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf

    10/21 01:30 am

    GlobeNewswire Inc.

    Read more
  • Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

    10/21 01:30 am

    GlobeNewswire Inc.

    Read more
  • NCBCP Celebrates President & CEO, Melanie L. Campbell's 30 Years of Leadership and Service During the 28th Annual Spirit of Democracy Awards Gala

    10/20 03:45 pm

    Benzinga

    Read more
  • Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Oncology (ESMO) Congress

    10/18 03:00 am

    GlobeNewswire Inc.

    Read more
  • UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

    10/17 12:43 pm

    Benzinga

    Read more
  • Merck's New HIV Treatment Works As Well As Top Drug In Late Trials

    10/15 12:23 pm

    Benzinga

    Read more
  • Multiple Myeloma CAR-T Market Set for Rapid Growth Driven by BCMA-Targeted Therapies and Innovative Advances

    10/08 11:00 am

    GlobeNewswire Inc.

    Read more
  • Gene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare

    10/08 10:00 am

    GlobeNewswire Inc.

    Read more
  • Immatics Appoints Venkat Ramanan as Chief Financial Officer

    10/01 07:00 am

    GlobeNewswire Inc.

    Read more
  • Top Security Executives Recognized at the 2025 BayAreaCISO ORBIE Awards

    09/25 03:49 pm

    GlobeNewswire Inc.

    Read more
  • Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025

    09/17 10:44 pm

    GlobeNewswire Inc.

    Read more
  • Biotech Sector May Flip to Market Leader by Year-End

    09/15 01:25 pm

    Investing.com

    Read more
  • Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

    09/04 11:00 am

    GlobeNewswire Inc.

    Read more
  • Pharming Group appoints Kenneth Lynard as Chief Financial Officer

    09/02 01:00 am

    GlobeNewswire Inc.

    Read more
  • Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy

    08/21 11:45 am

    Benzinga

    Read more
  • Ligand to Participate in September Investor Conferences

    08/19 04:00 pm

    GlobeNewswire Inc.

    Read more
  • MacroGenics Revenue Doubles in Q2

    08/14 04:21 pm

    The Motley Fool

    Read more
  • Kymera Revenue Drops 55 Percent in Q2

    08/11 07:28 am

    The Motley Fool

    Read more
  • Tango (TNGX) Q2 Revenue Drops 52%

    08/05 08:25 pm

    The Motley Fool

    Read more
  • IDEAYA (IDYA) Q2 Net Loss Improves 27%

    08/05 04:23 pm

    The Motley Fool

    Read more
  • MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Report 2025: Over 12 ML1 Inhibitor Drugs In Clinical Trials

    08/05 04:28 am

    GlobeNewswire Inc.

    Read more
  • Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales

    07/25 12:12 pm

    Benzinga

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

    07/06 10:00 am

    GlobeNewswire Inc.

    Read more
  • Why Gilead Scinces Stock Tumbled on Tuesday

    06/10 05:22 pm

    The Motley Fool

    Read more
  • 2 Stocks, 100%+ Combined Gains - All From Spotting Mispricing Before the Crowd

    06/08 03:45 am

    Investing.com

    Read more
  • Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

    06/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

    06/05 06:38 pm

    GlobeNewswire Inc.

    Read more
  • Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités

    05/09 10:46 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

    04/28 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer

    04/21 02:49 pm

    Benzinga

    Read more
  • 2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around

    04/17 05:45 am

    The Motley Fool

    Read more
  • 2 Top Dividend Stocks That Could Set You Up for Life

    04/09 07:00 am

    The Motley Fool

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: